Evidence map›Paper›PMID 32060938›Full record

ArticleHepatology (Baltimore, Md.)2020

Susceptibility of Rat Steatotic Liver to Ischemia-Reperfusion Is Treatable With Liver-Selective Matrix Metalloproteinase Inhibition.

Xiangdong Wang, Christopher J Walkey, Ana C Maretti-Mira, Lei Wang, Deborah L Johnson, Laurie D DeLeve

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. A Multidrug Donor Preconditioning Improves Steatotic Rat Liver Allograft Function and Recipient Survival After Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
  12. Article
  13. Review
  14. Responses of hepatic sinusoidal cells to liver ischemia-reperfusion injury.Frontiers in cell and developmental biology · 2023
    Review
  15. Acteoside ameliorates hepatic ischemia-reperfusion injuryInternational journal of biological sciences · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Role of liver sinusoidal endothelial cells in liver diseases.Nature reviews. Gastroenterology & hepatology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiangdong WangUSC Division of Gastrointestinal and Liver Disease and the USC Research Center for Liver Disease, Keck Medicine of USC, Los Angeles, CA.
Christopher J WalkeyDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.ORCID 0000-0002-1471-0447
Ana C Maretti-MiraUSC Division of Gastrointestinal and Liver Disease and the USC Research Center for Liver Disease, Keck Medicine of USC, Los Angeles, CA.ORCID 0000-0002-6252-2811
Lei WangUSC Division of Gastrointestinal and Liver Disease and the USC Research Center for Liver Disease, Keck Medicine of USC, Los Angeles, CA.
Deborah L JohnsonDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.
Laurie D DeLeveUSC Division of Gastrointestinal and Liver Disease and the USC Research Center for Liver Disease, Keck Medicine of USC, Los Angeles, CA.ORCID 0000-0002-8951-5689
Keck Hospital of USC · USBaylor College of Medicine · US

Funding

USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OOKHTENS, MURAD · 1995 to 2020
$21.8M
PATHO OF EXPERIMENTAL HEPATIC VENOOCCLUSIVE DISEASER01DK046357 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DELEVE, LAURIE D · 1999 to 2017
$4.3M
Liver sinusoidal endothelial cells and fibrosis.R01DK100580 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DELEVE, LAURIE D · 2014 to 2023
$2.9M
Determinants of Sinusoidal Endothelial Cell Phenotype.R01DK066423 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DELEVE, LAURIE D · 2003 to 2011
$2.7M
MECHANISMS OF TOXICITY IN SINUSOIDAL ENDOTHELIAL CELLSR29DK046357 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DELEVE, LAURIE D · 1994 to 1998
–
NIDDK NIH HHS 100580NIDDK NIH HHS 46357NIDDK NIH HHS P30 DK048522NIDDK NIH HHS R01 DK046357NIDDK NIH HHS R01 DK066423NIDDK NIH HHS R01 DK100580
6 · The paper itself

Abstract

BACKGROUND AND

aimsThis study examined whether enhanced susceptibility of steatotic liver to ischemia-reperfusion (I/R) injury is due to impaired recruitment of bone marrow (BM) progenitors of liver sinusoidal endothelial cells (LSECs, also called sinusoidal endothelial cell progenitor cells [sprocs]) with diminished repair of injured LSECs and whether restoring signaling to recruit BM sprocs reduces I/R injury. APPROACH AND

resultsHepatic vessels were clamped for 1 hour in rats fed a high-fat, high-fructose (HFHF) diet for 5, 10, or 15 weeks. Matrix metalloproteinase 9 (MMP-9) antisense oligonucleotides (ASO) or an MMP inhibitor were used to induce liver-selective MMP-9 inhibition. HFHF rats had mild, moderate, and severe steatosis, respectively, at 5, 10, and 15 weeks. I/R injury was enhanced in HFHF rats; this was accompanied by complete absence of hepatic vascular endothelial growth factor (VEGF)-stromal cell-derived factor 1 (sdf1) signaling, leading to lack of BM sproc recruitment. Liver-selective MMP-9 inhibition to protect against proteolytic cleavage of hepatic VEGF using either MMP-9 ASO or intraportal MMP inhibitor in 5-week and 10-week HFHF rats enhanced hepatic VEGF-sdf1 signaling, increased BM sproc recruitment, and reduced alanine aminotransferase (ALT) by 92% and 77% at 5 weeks and by 80% and 64% at 10 weeks of the HFHF diet, respectively. After I/R injury in 15-week HFHF rats, the MMP inhibitor reduced active MMP-9 expression by 97%, ameliorated histologic evidence of injury, and reduced ALT by 58%, which is comparable to control rats sustaining I/R injury. Rescue therapy with intraportal MMP inhibitor, given after ischemia, in the 5-week HFHF rat reduced ALT by 71% and reduced necrosis.

conclusionsLack of signaling to recruit BM sprocs that repair injured LSECs renders steatotic liver more susceptible to I/R injury. Liver-selective MMP-9 inhibition enhances VEGF-sdf1 signaling and recruitment of BM sprocs, which markedly protects against I/R injury, even in severely steatotic rats.

Indexed as

AnimalsBone Marrow TransplantationDietary SugarsDiet, High-FatDisease Models, AnimalDisease SusceptibilityEndothelial Progenitor CellsFatty LiverFructoseHumansLiverMaleMatrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsMicrovesselsRatsDietary SugarsFructoseMatrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsMmp9 protein, rat

Identifiers

PMID32060938
PMCPMC7523533
OpenAlexW3006274265

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.